Click a link below to view the mailing archive as if it had been sent to you.
| 2022-08-31 12:15 | | Patient groups sue feds to crack down on insurer, PBM copay adjustment programs and more... |
| 2022-08-31 00:15 | | FDA Opens Review Into Opioid Prescribing, Warning Regulations and more... |
| 2022-08-30 12:15 | | Abbott Gets to the Heart of Extending Life-Expectancy with HeartMate 3 Data and more... |
| 2022-08-29 12:15 | | AstraZeneca’s Farxiga reduces CV mortality risk in Phase III trials and more... |
| 2022-08-29 00:15 | | Gilead hits back at Bristol Myers' Supreme Court petition in CAR-T patent feud and more... |
| 2022-08-27 00:15 | | Moderna sues Pfizer, BioNTech over COVID-19 vaccine technology and more... |
| 2022-08-26 12:15 | | Multiple monkeypox vaccine and antiviral trials are launching across the world and more... |
| 2022-08-26 00:15 | | Regen BioPharma Develops Novel Means of Using CAR-T cell Immunotherapy to Attack Solid Tumors and more... |
| 2022-08-25 12:15 | | It's a spinoff: Novartis parts ways with Sandoz just as its generics biz shows signs of recovery and more... |
| 2022-08-25 00:15 | | Inovio agrees to shell out $44M to settle Covid-19 vaccine lawsuit and more... |
| 2022-08-24 12:15 | | Pharma's new marketing mix brings closer collaboration with sales reps and more... |
| 2022-08-24 00:15 | | Medtronic still eyeing modest year-over-year growth as fiscal 2023 kicks off with slipping revenues and more... |
| 2022-08-23 12:15 | | Aerie’s glaucoma drug journey ends in $770M sale to Alcon and more... |
| 2022-08-23 00:15 | | Pfizer, BioNTech submit omicron booster for FDA clearance and more... |
| 2022-08-22 12:15 | | 3 Biopharmas on Buyout Watch and more... |
| 2022-08-22 00:15 | | Study: Most accelerated approval indications don’t add high therapeutic value and more... |
| 2022-08-19 12:15 | | Novartis' MS drug Gilenya could inspire new chronic kidney disease treatment and more... |
| 2022-08-19 00:15 | | Ivermectin and Others Flunk Severe COVID-19 Study, Vaccine Development Lawsuits Mount and more... |
| 2022-08-18 12:15 | | FDA lifts partial hold on Curis' lymphoma study — shares spike and more... |
| 2022-08-18 00:15 | | Did Sarepta Therapeutics Just Unveil a Breakthrough? and more... |
| 2022-08-17 12:15 | | GenScript Launches Expedited mRNA Service for Research and Pre-Clinical Applications and more... |
| 2022-08-17 00:15 | | AbbVie calls off PhI trial for I-Mab’s CD47 days after Zai Lab shelves its own program and more... |
| 2022-08-16 12:15 | | Roche’s Polivy continues its regulatory dance, will head to FDA for a form of blood cancer and more... |
| 2022-08-15 12:15 | | UK becomes first country to approve updated Moderna vaccine targeting omicron and more... |
| 2022-08-15 00:15 | | House sends drug pricing reforms to President Biden’s desk and more... |
| 2022-08-12 12:15 | | After billions in legal costs, Johnson & Johnson plans to halt talc sales worldwide and more... |
| 2022-08-12 00:15 | | Novartis reports deaths of two patients treated with Zolgensma gene therapy and more... |
| 2022-08-11 12:15 | | Moderna CEO touts plan for triple combo respiratory shot in 'three to five years': report and more... |
| 2022-08-11 00:15 | | Gut Check: How Is Diabetes Tech Holding up in 2022? and more... |
| 2022-08-10 12:15 | | Amid $1B downsizing, Biogen lists Boston-area office space for sublease and more... |
| 2022-08-10 00:15 | | Mount Sinai launches vaccine company for 'inevitable' future pandemics and more... |
| 2022-08-09 12:15 | | Merck is back in Alzheimer's saddle with $1B+ Cerevance pact, years after dropping the BACE and more... |
| 2022-08-09 00:15 | | GSK bets $1.3B on Mersana’s preclinical ADC and chance to expand portfolio beyond Blenrep and more... |
| 2022-08-08 12:15 | | Pfizer buys sickle cell drugmaker Global Blood for $5.4B and more... |
| 2022-08-08 00:15 | | In a massive victory for Democrats, Medicare is poised to negotiate drug prices and more... |
| 2022-08-05 12:15 | | Lilly takes long view on Alzheimer’s drug hopeful as FDA starts expedited review and more... |
| 2022-08-05 00:15 | | Gilead Sciences to acquire Oxford University biotech spinout MiroBio for $405M and more... |
| 2022-08-04 12:15 | | Alnylam drug succeeds in heart study, setting stage for FDA filing and showdown with Pfizer and more... |
| 2022-08-04 00:15 | | ResMed Strengthens Sleep Portfolio with Mementor Acquisition and more... |
| 2022-08-03 12:15 | | Virtual Incision opens new frontier for robotic surgery with space station mission and more... |
| 2022-08-03 00:15 | | How Belite Bio, a small, under-the-radar drugmaker, emerged as one of biotech’s best performing IPOs and more... |
| 2022-08-02 12:15 | | Racing Merck and Pfizer, Roche readies to file subcutaneous Tecentriq after posting phase 3 data and more... |
| 2022-08-02 00:15 | | Nuvation to cut workforce by 35% as it scraps lead drug program and more... |
| 2022-08-01 12:15 | | Lilly, AZ, AbbVie and J&J face big potential hit from Medicare pricing bill: analysts and more... |
